Randomized study of vaginal and neonatal cleansing with 1% chlorhexidine

Leonardo Pereira, Tsungai Chipato, Alexio Mashu, Velda Mushangwe, Simbarashe Rusakaniko, Shrikant I. Bangdiwala, Office Samson Chidede, Gary L. Darmstadt, Lovemore Gwanzura, Gwendoline Kandawasvika, Simon Madzime, Pisake Lumbiganon, Jorge Tolosa

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To determine the safety, acceptability, and antimicrobial effect of 1% chlorhexidine (CHX) vaginal washing of women in labor and their neonates. Methods: Randomized controlled trial of 1% CHX vaginal and neonatal washing compared with no washing (usual care [UC]). The study included 502 women (334 CHX, 168 UC) who delivered 508 liveborn neonates (335 CHX, 173 UC). Main outcome measures were the incidence of maternal adverse effects, the incidence of neonatal skin rash, the axillary temparature before and after neonatal wiping, and vaginal culture results. Results: Maternal demographics did not differ between the groups. No case of maternal rash occured; 4% of women experienced vaginal burning. An axillary temperature drop of more than 1 °C after CHX cleansing occurred in 8 neonates; 2 neonates had a minor rash. In the subset of women with positive vaginal cultures as baseline, 1% CHX eliminated culture growth in 56% after 1 wash, and in 86% after 2 washes. Conclusions: Use of 1% CHX is safe for neonates, well tolerated by laboring mothers, and effective in treating vaginal infections during labor. A randomized controlled trial using 1% CHX and powered for a reduction in neonatal septic mortality is justified based on these data.

Original languageEnglish (US)
Pages (from-to)234-238
Number of pages5
JournalInternational Journal of Gynecology and Obstetrics
Volume112
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Chlorhexidine
Newborn Infant
Exanthema
Mothers
Randomized Controlled Trials
Incidence
Infant Mortality
Demography
Outcome Assessment (Health Care)
Safety
Temperature
Growth
Infection

Keywords

  • Chlorhexidine
  • Neonatal sepsis
  • Vaginal washing

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Randomized study of vaginal and neonatal cleansing with 1% chlorhexidine. / Pereira, Leonardo; Chipato, Tsungai; Mashu, Alexio; Mushangwe, Velda; Rusakaniko, Simbarashe; Bangdiwala, Shrikant I.; Chidede, Office Samson; Darmstadt, Gary L.; Gwanzura, Lovemore; Kandawasvika, Gwendoline; Madzime, Simon; Lumbiganon, Pisake; Tolosa, Jorge.

In: International Journal of Gynecology and Obstetrics, Vol. 112, No. 3, 03.2011, p. 234-238.

Research output: Contribution to journalArticle

Pereira, L, Chipato, T, Mashu, A, Mushangwe, V, Rusakaniko, S, Bangdiwala, SI, Chidede, OS, Darmstadt, GL, Gwanzura, L, Kandawasvika, G, Madzime, S, Lumbiganon, P & Tolosa, J 2011, 'Randomized study of vaginal and neonatal cleansing with 1% chlorhexidine', International Journal of Gynecology and Obstetrics, vol. 112, no. 3, pp. 234-238. https://doi.org/10.1016/j.ijgo.2010.09.009
Pereira, Leonardo ; Chipato, Tsungai ; Mashu, Alexio ; Mushangwe, Velda ; Rusakaniko, Simbarashe ; Bangdiwala, Shrikant I. ; Chidede, Office Samson ; Darmstadt, Gary L. ; Gwanzura, Lovemore ; Kandawasvika, Gwendoline ; Madzime, Simon ; Lumbiganon, Pisake ; Tolosa, Jorge. / Randomized study of vaginal and neonatal cleansing with 1% chlorhexidine. In: International Journal of Gynecology and Obstetrics. 2011 ; Vol. 112, No. 3. pp. 234-238.
@article{960e2f07cf074c10b83708d71ecb36ba,
title = "Randomized study of vaginal and neonatal cleansing with 1{\%} chlorhexidine",
abstract = "Objective: To determine the safety, acceptability, and antimicrobial effect of 1{\%} chlorhexidine (CHX) vaginal washing of women in labor and their neonates. Methods: Randomized controlled trial of 1{\%} CHX vaginal and neonatal washing compared with no washing (usual care [UC]). The study included 502 women (334 CHX, 168 UC) who delivered 508 liveborn neonates (335 CHX, 173 UC). Main outcome measures were the incidence of maternal adverse effects, the incidence of neonatal skin rash, the axillary temparature before and after neonatal wiping, and vaginal culture results. Results: Maternal demographics did not differ between the groups. No case of maternal rash occured; 4{\%} of women experienced vaginal burning. An axillary temperature drop of more than 1 °C after CHX cleansing occurred in 8 neonates; 2 neonates had a minor rash. In the subset of women with positive vaginal cultures as baseline, 1{\%} CHX eliminated culture growth in 56{\%} after 1 wash, and in 86{\%} after 2 washes. Conclusions: Use of 1{\%} CHX is safe for neonates, well tolerated by laboring mothers, and effective in treating vaginal infections during labor. A randomized controlled trial using 1{\%} CHX and powered for a reduction in neonatal septic mortality is justified based on these data.",
keywords = "Chlorhexidine, Neonatal sepsis, Vaginal washing",
author = "Leonardo Pereira and Tsungai Chipato and Alexio Mashu and Velda Mushangwe and Simbarashe Rusakaniko and Bangdiwala, {Shrikant I.} and Chidede, {Office Samson} and Darmstadt, {Gary L.} and Lovemore Gwanzura and Gwendoline Kandawasvika and Simon Madzime and Pisake Lumbiganon and Jorge Tolosa",
year = "2011",
month = "3",
doi = "10.1016/j.ijgo.2010.09.009",
language = "English (US)",
volume = "112",
pages = "234--238",
journal = "International Journal of Gynecology and Obstetrics",
issn = "0020-7292",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Randomized study of vaginal and neonatal cleansing with 1% chlorhexidine

AU - Pereira, Leonardo

AU - Chipato, Tsungai

AU - Mashu, Alexio

AU - Mushangwe, Velda

AU - Rusakaniko, Simbarashe

AU - Bangdiwala, Shrikant I.

AU - Chidede, Office Samson

AU - Darmstadt, Gary L.

AU - Gwanzura, Lovemore

AU - Kandawasvika, Gwendoline

AU - Madzime, Simon

AU - Lumbiganon, Pisake

AU - Tolosa, Jorge

PY - 2011/3

Y1 - 2011/3

N2 - Objective: To determine the safety, acceptability, and antimicrobial effect of 1% chlorhexidine (CHX) vaginal washing of women in labor and their neonates. Methods: Randomized controlled trial of 1% CHX vaginal and neonatal washing compared with no washing (usual care [UC]). The study included 502 women (334 CHX, 168 UC) who delivered 508 liveborn neonates (335 CHX, 173 UC). Main outcome measures were the incidence of maternal adverse effects, the incidence of neonatal skin rash, the axillary temparature before and after neonatal wiping, and vaginal culture results. Results: Maternal demographics did not differ between the groups. No case of maternal rash occured; 4% of women experienced vaginal burning. An axillary temperature drop of more than 1 °C after CHX cleansing occurred in 8 neonates; 2 neonates had a minor rash. In the subset of women with positive vaginal cultures as baseline, 1% CHX eliminated culture growth in 56% after 1 wash, and in 86% after 2 washes. Conclusions: Use of 1% CHX is safe for neonates, well tolerated by laboring mothers, and effective in treating vaginal infections during labor. A randomized controlled trial using 1% CHX and powered for a reduction in neonatal septic mortality is justified based on these data.

AB - Objective: To determine the safety, acceptability, and antimicrobial effect of 1% chlorhexidine (CHX) vaginal washing of women in labor and their neonates. Methods: Randomized controlled trial of 1% CHX vaginal and neonatal washing compared with no washing (usual care [UC]). The study included 502 women (334 CHX, 168 UC) who delivered 508 liveborn neonates (335 CHX, 173 UC). Main outcome measures were the incidence of maternal adverse effects, the incidence of neonatal skin rash, the axillary temparature before and after neonatal wiping, and vaginal culture results. Results: Maternal demographics did not differ between the groups. No case of maternal rash occured; 4% of women experienced vaginal burning. An axillary temperature drop of more than 1 °C after CHX cleansing occurred in 8 neonates; 2 neonates had a minor rash. In the subset of women with positive vaginal cultures as baseline, 1% CHX eliminated culture growth in 56% after 1 wash, and in 86% after 2 washes. Conclusions: Use of 1% CHX is safe for neonates, well tolerated by laboring mothers, and effective in treating vaginal infections during labor. A randomized controlled trial using 1% CHX and powered for a reduction in neonatal septic mortality is justified based on these data.

KW - Chlorhexidine

KW - Neonatal sepsis

KW - Vaginal washing

UR - http://www.scopus.com/inward/record.url?scp=79951677259&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951677259&partnerID=8YFLogxK

U2 - 10.1016/j.ijgo.2010.09.009

DO - 10.1016/j.ijgo.2010.09.009

M3 - Article

C2 - 21247573

AN - SCOPUS:79951677259

VL - 112

SP - 234

EP - 238

JO - International Journal of Gynecology and Obstetrics

JF - International Journal of Gynecology and Obstetrics

SN - 0020-7292

IS - 3

ER -